Security key
528872302
LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX)
CUSIP: 528872302
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 288,616,985
- Total 13F value
- $453,067,592
- Share change
- -30,804,688
- Put/Call ratio
- 29%
- SEC-reported price per share
- $1.57
- Number of holders
- 134
- Value change
- -$48,604,221
- Number of buys
- 66
- Number of sells
- 33
- Shares outstanding
- 442,581,578
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
134
Top holders
10
LXRX full security history
Ownership snapshot
Full 13F holder table
LEXICON PHARMACEUTICALS, INC. SEC filings
LEXICON PHARMACEUTICALS, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Artal Group S.A.
Disclosed value leader
Artal Group S.A.
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 40%
Showing 1-6 of 15 holder rows.
Quick read
Artal Group S.A. leads the comparable SEC ownership view at 40%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Artal Group S.A.'s linked filing trail.
Comparable ownership
Top 5
Artal Group S.A.
40%
FMR LLC
8.7%
BlackRock Finance, Inc.
2.2%
BRAIDWELL LP
1.9%
VANGUARD GROUP INC
1.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Artal Group S.A. |
13F
Company
|
40%
|
$294,166,966
175,099,384 shares
|
— | 30 Jun 2024 |
| FMR LLC |
13F
Company
|
8.7%
|
$64,994,367
38,687,123 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
2.2%
|
$16,615,457
9,890,153 shares
|
— | 30 Jun 2024 |
| BRAIDWELL LP |
13F
Company
|
1.9%
|
$13,935,516
8,294,950 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
1.7%
|
$12,894,211
7,675,125 shares
|
— | 30 Jun 2024 |
| ORBIMED ADVISORS LLC |
13F
Company
|
1.3%
|
$9,821,448
5,846,100 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
134
Shares
288,616,985
Rows available
134
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
121
Q3 2024 holders
134
Holder diff
13
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|